TABLE 1.
Study | Selection of participants free from bias | Study with >80% follow up a | Standard/valid/reliable data collection procedures | QCC b , c rating |
---|---|---|---|---|
Calabrese et al. (2022) | Yes | No | Yes | ∅ |
Cheng et al. (2022) | Yes | No | Yes | ∅ |
Cronin et al. (2018) | Yes | Yes | Yes | + |
Cronin et al. (2019) | Yes | No | Yes | ∅ |
Dupuit et al. (2022) | Yes | No | Yes | ∅ |
Kern et al. (2020) | Yes | No | Yes | ∅ |
Liu et al. (2020) | Yes | Yes | Yes | ∅ |
Mahdieh et al. (2021) | Yes | Yes | Yes | + |
Moitinho-Silva et al. (2021) | Yes | Yes | Yes | ∅ |
Mokhtarzade et al. (2021) | Yes | Yes | Yes | + |
Morita et al. (2019) | No | Yes | Yes | ∅ |
Motiani et al. (2020) | Yes | No | Yes | + |
Resende et al. (2021) | Yes | Yes | Yes | + |
Sun et al. (2022) | Yes | No | Yes | ∅ |
Taniguchi et al. (2018) | Yes | Yes | Yes | + |
Torquati et al. (2022) | Yes d | No | Yes | ∅ |
Warbeck et al. (2021) | Yes | No | Yes | ∅ |
Wei et al. (2022) | Yes | No | Yes | ∅ |
Zhong et al. (2020) | Yes | Yes | Yes | + |
Follow-up here takes into account participant attrition or participants included in analysis.
QCC, quality criteria checklist.
QCC, rating: +, report has clearly addressed issues of inclusion/exclusion, bias, generalizability, and data collection and analysis; ∅, report is neither exceptionally strong nor exceptionally weak.
Original study.